• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE EXCLUDER AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number PLC231000
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Date of Event 06/01/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Patient medical history incudes but is not limited to: thombocytopenia, gerd w/out esophagitis, popliteal aneurysm, perforated nasal septum, mixed hyperlipidemia, arterial aneurysm, hypertension, etd.Patient medications include but are not limited to: losartan, prilosec, plavix, tylenol, multivitamin.According to the gore excluder® aaa endoprostheses instructions for use, adverse events that may occur and/or require intervention include, but are not limited to: endoleaks.
 
Event or Problem Description
On (b)(6) 2017, this patient underwent treatment for an abdominal aortic aneurysm and a right common iliac artery aneurysm (rciaa) and was implanted with gore® excluder® aaa endoprostheses and gore® excluder® lliac branch endoprostheses.The patient tolerated the procedure.On (b)(6) 2021, the patient underwent reintervention to treat a distal type i endoleak associated with a 23 contralateral leg component used to extend coverage on the left side due to elongation of the internal iliac artery and a full occlusion of the left internal iliac artery.Two additional contralateral leg components were placed distally on the left side.The endoleak was resolved.The patient tolerated the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE EXCLUDER AAA ENDOPROSTHESIS
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key12081722
Report Number2953161-2021-01068
Device Sequence Number3503311
Product Code MIH
UDI-Device Identifier00733132618576
UDI-Public00733132618576
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P020004
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Reporter Type Manufacturer
Report Source health professional
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 06/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/01/2019
Device Model NumberPLC231000
Device Catalogue NumberPLC231000
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/01/2021
Initial Report FDA Received Date06/28/2021
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Other; Required Intervention;
Patient Age56 YR
Patient Weight84
-
-